Skip to content
OpenCapital
Get started

4D Molecular Therapeutics FDMT Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
107.7M-3.1%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
256.3M-1.2%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
86M+23.3%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Regenxbio logo
RegenxbioRGNX
52.4M+1.9%

Other financials

Income statement

See full
Revenue$3.0M+21,664%
Operating income-$73.6M-37.3%
Net income-$68.8M-43.3%
EPS (diluted)-$1.01-17.4%

Balance sheet

See full
Cash & equivalents$72.5M-45.7%
Total debt$20.5M-13.9%
Total equity$451.8M-3.8%
Total assets$512.9M-0.5%

Cash flow

See full
Operating cash flow-$68.1M-42.6%
CapEx--100%
Free cash flow-$68.1M-40.8%

Valuation

See full
Market cap$602.22M+215%
Enterprise value$550.27M+574%
P/S6.8×-8,306×

Profitability

See full
Operating margin-220.1%-110pp
Net margin-174,314.2%-62,763pp
FCF margin-154,209.2%-53,057pp

Returns & leverage

See full
Return on equity-45.4%+29.8pp
Debt / equity0×0.0×
Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 4D Molecular Therapeutics's shares (diluted)?
4D Molecular Therapeutics (FDMT) reported shares (diluted) of 68.1M in Q1 2026.
How has 4D Molecular Therapeutics's shares (diluted) changed year-over-year?
4D Molecular Therapeutics's shares (diluted) increased by 22.1% year-over-year, from 55.7M to 68.1M.
What is the long-term trend for 4D Molecular Therapeutics's shares (diluted)?
Over 4 years (2021 to 2025), 4D Molecular Therapeutics's shares (diluted) has grown at a 20.2% compound annual growth rate (CAGR), from 108.2M to 225.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.